Athira Pharma Inc

NASDAQ:ATHA  
24.07
+1.17 (+5.11%)
Other Pre-Announcement

Athira Pharma Reports Q3 2020 Results

Published: 11/12/2020 21:27 GMT
(ATHA) - Athira Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights.
Q3 Loss per Share $1.12.
Q3 Earnings per Share Estimate $-0.25 -- Refinitiv Ibes Data (analyst estimates).
Cash, Cash Equivalents and Investments Were $259.9 Million As of September 30, 2020, As Compared to $85.2 Million As of June 30, 2020.